½ÃÀ庸°í¼­
»óǰÄÚµå
86316

Áß±¹ÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ½ÃÀå

Alzheimer Disease Drugs Markets in China

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Asia Market Information & Development Co. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 239 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Áß±¹ÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦(Alzheimer Disease Drugs) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ¼ö¿ä¿Í ¾÷°è µ¿Çâ ¿¹Ãø°ú »ç¾÷ ȯ°æ, ½ÃÀå ÁøÃâ¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý
  • ÁÖ¿ä ¿ä¾à

Á¦2Àå »ç¾÷ ȯ°æ

  • °æÁ¦ Àü¸Á
  • ÁÖ¿ä °æÁ¦ÁöÇ¥
  • »ê¾÷ »ý»ê
  • Àα¸¿Í ³ëµ¿·Â
  • ¿Ü±¹ ÅõÀÚ
  • ¿Ü±¹ ¹«¿ª
  • À繫¿Í ¼¼±Ý ±ÔÁ¦
  • ÀºÇà ½Ã½ºÅÛ°ú ±ÔÁ¦
  • ¿Üȯ
  • ¼¼±Ý°ú °ü¼¼

Á¦3Àå ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ¾÷°è Æò°¡

  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ¾÷°è ±¸Á¶
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ÆÇ¸Å·®
  • ÁÖ¿ä »ý»ê ½Ã¼³ Àå¼Ò¿Í ÆÇ¸Å·®
  • ÁÖ¿ä »ý»ê¾÷ü ½ÃÀå Á¡À¯À²
  • ÀΰǺñ
  • ÀáÀçÀû ÁøÃâ ±â¾÷
  • ÁÖ¿ä ÆÇ¸Å¾÷ü
  • ÁÖ¿ä ÇØ¿Ü ÅõÀÚ
  • ±â¼ú °³¹ß

Á¦4Àå ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ »ý»ê°ú ¼ö¿ä

  • °³¿ä
  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ¼ö¿ä : Áö¿ªº°
  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ÆÇ¸Å·®
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • ±âŸ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦
  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ¼öÀÔ
  • Ginkgo Bilota Extract ¼öÀÔ
  • Breviscapine ¼öÀÔ
  • Ganglioside ¼öÀÔ
  • Donepezil ¼öÀÔ
  • Galanthamine ¼öÀÔ
  • Nicergoline ¼öÀÔ
  • Rivastigmine ¼öÀÔ
  • Memantine ¼öÀÔ
  • Huperzine A ¼öÀÔ
  • Oxiracetam ¼öÀÔ
  • Flunarizine ¼öÀÔ
  • Piracetam ¼öÀÔ
  • ±âŸ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ¼öÀÔ
  • °¡°Ý µ¿Çâ

Á¦5Àå ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ½ÃÀå Àü¸Á

  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ½ÃÀå Àü¸Á °³¿ä
  • Á¤ºÎ ±ÔÁ¦
  • ÀǷẸÇè ¾÷°è °³¿ä
  • ¼ÒºñÀÚ ÁöÃâ µ¿Çâ : Áö¿ªº°
  • Àα¸Åë°è µ¿Çâ
  • ÀÇ·á ¾÷°è µ¿Çâ
  • º´¿ø°ú º´»ó
  • ÀÇ»ç¿Í ÁøÂû

Á¦6Àå ¸¶ÄÉÆÃ Àü·«

  • Áß±¹ ½ÃÀå ÁøÃâ °³¿ä
  • Áß±¹ÀÇ À¯Åë ½Ã½ºÅÛ
  • ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ À¯Åë ä³Î
  • ¼ö¼Û°ú È­¹° ÀÎÇÁ¶ó
  • Ä¿¹Â´ÏÄÉÀ̼Ç
  • Áß±¹ ½ÃÀå ÁøÃâ
  • ¶óÀ̼±½Ì
  • ÇÁ·£Â÷ÀÌÁî
  • E-Commerce
  • »ó»ç¿Í ÇöÁö ´ë¸®Á¡
  • ÁÖÀç¿ø »ç¹«¼Ò¿Í Áß±¹ÀÇ ÀÚȸ»ç
  • ¿ÏÀü ¿ÜÀÚ ±â¾÷

Á¦7Àå ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ »ý»ê¾÷ü µð·ºÅ丮

  • ÁÖ¿ä ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ »ý»ê¾÷ü °³¿ä
  • ÆÇ¸Å¾÷ü¡¤»ó»ç
  • Çùȸ¡¤¿¬±¸±â°ü
  • ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ
KSM 23.01.11

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

V. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer's Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦